Effect of mutation and conformation on the function of p53 in colorectal cancer

Journal of Pathology

Volumn 191, Issue 4, 2000, Pages 361-367

  Webley, Katherine M ^a   Shorthouse, Andrew J ^b   Royds, Janice A ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Conformation; Mutation; p21(WAF 1); p53; Prognosis

Indexed keywords

DNA; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; DNA DAMAGE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENE EXPRESSION; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN CONFORMATION;

EID: 0033846450     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH660>3.0.CO;2-2     Document Type: Article

References (23)

1. Crystal structure of a p53 tumour suppressor-DNA complex: Understanding tumorigenic mutations
2. A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40
3. Evidence for allosteric variants of wild-type p53, a tumour suppressor protein
4. Monoclonal antibody analysis of p53 expression in normal and transformed cells
5. Activating mutations in p53 produce a common conformational effect: A monoclonal antibody specific for the mutant form
6. Temperature-dependent switching between 'wild-type' and 'mutant' forms of p53-Val135
7. 1 arrest in human cancer cells
8. p21/waf1 expression in human colorectal carcinoma: Association with p53, transcription factor AP-2 and prognosis
9. Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA
10. Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation of inhibition of cell proliferation
11. Specific DNA binding by different classes of human p53 mutants
12. p53 DNA binding can be modulated by factors that alter the conformational equilibrium
13. + conformation of wild-type p53 binds DNA
14. The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
15. Induced N- and C-terminal cleavage of p53: A core fragment of p53, generated interaction with damaged DNA., promotes cleavage of the N-terminus of full length p53, whereas ssDNA induces C-terminal cleavage of p53
16. Evolutionary conservation and somatic mutation hotspot maps of p53: Correlation with p53 protein structural and functional features
17. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
18. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway
19. p53: A glimpse of the puppet behind the shadow play
20. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer
21. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer
22. TP53 and long-term prognosis in colorectal cancer: Mutations in the L3 zinc-binding domain predict poor survival
23. p53 point mutations and survival in colorectal cancer